American Journal of Kidney Diseases
Volume 50, Issue 4 , Pages 552-558 , October 2007

GFR, Body Mass Index, and Low High-Density Lipoprotein Concentration in Adults With and Without CKD

  • Joan C. Lo, MD

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland
    • Department of Medicine, University of California San Francisco, San Francisco
    • Corresponding Author InformationAddress correspondence to Joan C. Lo, MD, Division of Research, Kaiser Permanente of Northern California, 2000 Broadway St, Oakland, CA 94612.
    • ,
  • Alan S. Go, MD

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland
    • Department of Medicine, University of California San Francisco, San Francisco
    • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco
    • ,
  • Malini Chandra, MS

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland
    • ,
  • Dongjie Fan, MSPH

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland
    • ,
  • George A. Kaysen, MD, PhD

      Affiliations

    • Department of Medicine, University of California Davis, Davis
    • Department of Biochemistry and Molecular Medicine, University of California Davis, Davis
    • Department of Veterans Affairs Northern California Health Care System, Mather, CA.

Received 3 January 2007 ,Accepted 5 July 2007.

References 

  1. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication No 98-4083. Bethesda, MD: National Institutes of Health; 1998;
  2. Young CE, Karas RH, Kuvin JT. High-density lipoprotein cholesterol and coronary heart disease. Cardiol Rev. 2004;12:107–119
  3. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol. 2005;16:529–538
  4. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–850
  5. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–880
  6. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
  7. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int. 2000;58:293–301
  8. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–174
  9. Vaziri ND. Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290:F262–F272
  10. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438
  11. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469–477
  12. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–2140
  13. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
  14. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–1876
  15. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453–1459
  16. Anderwald C, Roden M. Adipotoxicity and the insulin resistance syndrome. Pediatr Endocrinol Rev. 2004;1:310–319
  17. Mekki K, Bouchenak M, Lamri M, Remaoun M, Belleville J. Changes in plasma lecithin: Cholesterol acyltransferase activity, HDL(2), HDL(3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis. Atherosclerosis. 2002;162:409–417
  18. Mekki K, Bouchenak M, Remaoun M, Belleville JL. Effect of long-term hemodialysis on plasma lecithin: Cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: A 9-year longitudinal study. Med Sci Monit. 2004;10:CR439–CR446
  19. Miida T, Miyazaki O, Hanyu O, et al. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol. 2003;14:732–738
  20. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  22. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr)
  23. Landis JR, Gaughan C, Joffe M Investigators ftCS. Inter-laboratory serum creatinine (sCr) calibration study. J Am Soc Nephrol. 2003;14:294A;(abstr)
  24. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357–1363
  25. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  26. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9–17
  27. Eberly LE, Prineas R, Cohen JD, et al. Metabolic syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care. 2006;29:123–130
  28. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047–1052

 Originally published online as doi:10.1053/j.ajkd.2007.07.011 on September 7, 2007.

PII: S0272-6386(07)01040-2

doi: 10.1053/j.ajkd.2007.07.011

American Journal of Kidney Diseases
Volume 50, Issue 4 , Pages 552-558 , October 2007

Article Tools

* Image Usage & Resolution